The use of dimension detecting techniques can help identify both the circulating tumor micro-emboli and clusters, which may express the CD45 marker in some of the cells, therefore escaping methods that use CD45 antibodies negative selection (21, 28). The gene discussed is PTPRC; the disease is neoplasm.